Publications

Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.

Pereira, SM; Barreto, ML; PILGER, D; Cruz, AA; Sant'Anna, C; Hijjar, MA; Ichihara, MY; SANTOS, AC; Genser, B; RODRIGUES, LC;

2012

The Lancet infectious diseases, (2012).12 4 10.1016/S1473-3099(11)70285-7.

Mass Immunization Strategies.

HEYMANN, DL; Aylward, RB; Tangermann, RH;

2012

, Wiley (2012). 10.1002/9781118345313.ch31.

BCG: myths, realities, and the need for alternative vaccine strategies.

McShane, H; Jacobs, WR; FINE, PE; Reed, SG; McMurray, DN; Behr, M; Williams, A; Orme, IM;

2012

Tuberculosis (Edinburgh, Scotland), (2012).92 3 10.1016/j.tube.2011.12.003.

A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania.

Remes, P; Selestine, V; Changalucha, J; ROSS, DA; Wight, D; De Sanjosé, S; KAPIGA, S; HAYES, RJ; WATSON-JONES, D;

2012

Vaccine, (2012).30 36 10.1016/j.vaccine.2012.06.025.

Vaccination of health care workers to protect patients at increased risk for acute respiratory disease.

Dolan, GP; HARRIS, RC; Clarkson, M; Sokal, R; Morgan, G; Mukaigawara, M; Horiuchi, H; Hale, R; Stormont, L; Béchard-Evans, L; Chao, Y-S; Eremin, S; Martins, S; Tam, JS; Peñalver, J; Zanuzdana, A; Nguyen-Van-Tam, JS;

2012

Emerging infectious diseases, (2012).18 8 10.3201/eid1808.111355.

Variability between countries in cytokine responses to BCG vaccination: what impact might this have on protection?.

DOCKRELL, HM; SMITH, SG; Lalor, MK;

2012

Expert review of vaccines, (2012).11 2 10.1586/erv.11.186.

Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination.

SMITH, SG; Lecher, S; BLITZ, R; Locht, C; DOCKRELL, HM;

2012

European journal of immunology, (2012).42 9 10.1002/eji.201142297.

Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design.

Bonsignori, M; Montefiori, DC; Wu, X; Chen, X; Hwang, K-K; Tsao, C-Y; Kozink, DM; Parks, RJ; Tomaras, GD; Crump, JA; KAPIGA, SH; Sam, NE; Kwong, PD; Kepler, TB; Liao, H-X; Mascola, JR; Haynes, BF;

2012

Journal of virology, (2012).86 8 10.1128/JVI.07163-11.

The globalization of risk and risk perception: why we need a new model of risk communication for vaccines.

LARSON, H; Brocard Paterson, P; ERONDU, N;

2012

Drug safety, (2012).35 11 10.1007/BF03261991.

Economic evaluations of childhood influenza vaccination: a critical review.

Newall, AT; JIT, M; Beutels, P;

2012

PharmacoEconomics, (2012).30 8 10.2165/11599130-000000000-00000.